Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 5/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5607772 | 0.91 | L3MBTL1 (0.35) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL9644015 | 0.87 | L3MBTL1 (0.38) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL5836615 | 0.84 | L3MBTL1 (0.37) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL21301194 | 0.84 | LMNA (0.44) | L3MBTL1ALDH1A1MGLL | |
| SCHEMBL14783541 | 0.84 | L3MBTL1 (0.37) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL16901532 | 0.84 | L3MBTL1 (0.37) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL1323996 | 0.84 | NLRP3 (0.41) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL18131857 | 0.82 | MGLL (0.40) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 | |
| SCHEMBL14003899 | 0.82 | LMNA (0.46) | MGLL | |
| SCHEMBL18131859 | 0.82 | MGLL (0.40) | L3MBTL1MAPK1ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024150897-A1 | FOAMING AGENT COMPOSITION FOR POLYURETHANE AND METHOD OF PREPARING POLYURETHANE FOAM USING SAME | 주식회사 세호 | 2024-07-18 | — | — | WO | claimed |
| US-20170022164-A1 | QUINOLONE-3-DIARYLETHERS | UNIV OREGON HEALTH & SCIENCE (US) | 2017-01-26 | — | — | US | claimed |
| WO-2017015360-A1 | QUINOLONE-3-DIARYLETHERS | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2017-01-26 | — | — | WO | claimed |
| US-4584408-A | Preparation of 1,3-bis(aryloxy)-2-propanols | THE DOW CHEMICAL COMPANY (US) | 1986-04-22 | — | — | US | claimed |
| WO-2024150897-A1 | FOAMING AGENT COMPOSITION FOR POLYURETHANE AND METHOD OF PREPARING POLYURETHANE FOAM USING SAME | 주식회사 세호 | 2024-07-18 | — | — | WO | disclosed |
| CN-118344641-A | Blowing agent composition for polyurethane and method for preparing polyurethane foam using the same | 世好 | 2024-07-16 | — | — | CN | disclosed |
| CN-115023455-A | Foamed polyurethane composition | 美国主席团有限公司 | 2022-09-06 | — | — | CN | disclosed |
| EP-3950855-A1 | NON-ISOCYANATE POLYURETHANE INKS FOR 3D PRINTING | 3D Systems, Incorporated (US) | 2022-02-09 | — | — | EP | disclosed |
| US-20200157053-A1 | Method of Treating or Inhibiting Malaria | UNIV OREGON HEALTH & SCIENCE (US) | 2020-05-21 | — | — | US | disclosed |
| US-10584098-B2 | Quinolone-3-diarylethers | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2020-03-10 | — | — | US | disclosed |
| US-20180362465-A1 | QUINOLONE-3-DIARYLETHERS | UNIV OREGON HEALTH & SCIENCE (US) | 2018-12-20 | — | — | US | disclosed |
| EP-3066088-B1 | CYCLIC CARBONATE AZIDE | AKZO NOBEL CHEMICALS INT BV (NL) | 2017-12-06 | — | — | EP | disclosed |
| US-9562114-B2 | Cyclic carbonate azide | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2017-02-07 | — | — | US | disclosed |
| US-20170022164-A1 | QUINOLONE-3-DIARYLETHERS | UNIV OREGON HEALTH & SCIENCE (US) | 2017-01-26 | — | — | US | disclosed |
| WO-2017015360-A1 | QUINOLONE-3-DIARYLETHERS | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2017-01-26 | — | — | WO | disclosed |
| US-20160280805-A1 | Cyclic Carbonate Azide | WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT (GB) | 2016-09-29 | — | — | US | disclosed |
| US-5091543-A | Reacting 1,2- or 1,3-diol with acrylic diester of carbonic acid | ARCO CHEMICAL TECHNOLOGY, INC. (US) | 1992-02-25 | — | — | US | disclosed |
| US-4584408-A | Preparation of 1,3-bis(aryloxy)-2-propanols | THE DOW CHEMICAL COMPANY (US) | 1986-04-22 | — | — | US | disclosed |
| US-4584408-A | Preparation of 1,3-bis(aryloxy)-2-propanols | THE DOW CHEMICAL COMPANY (US) | 1986-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180362465-A1 | QUINOLONE-3-DIARYLETHERS | RECQL, ELANE, ELF3 | L3MBTL1 2274/4885MAPK1 4574/4885ALDH1A1 2150/4885 |
| US-20170022164-A1 | QUINOLONE-3-DIARYLETHERS | RECQL, ELANE, ELF3 | L3MBTL1 2274/4885MAPK1 4574/4885ALDH1A1 2150/4885 |
| US-10584098-B2 | Quinolone-3-diarylethers | RECQL, ELANE, ELF3 | L3MBTL1 2274/4885MAPK1 4574/4885ALDH1A1 2150/4885 |
| US-20160280805-A1 | Cyclic Carbonate Azide | ATXN2L, ATXN10, CYCS | L3MBTL1 2579/4885MAPK1 770/4885ALDH1A1 3084/4885 |
| US-20200157053-A1 | Method of Treating or Inhibiting Malaria | ELANE, ELF3, ELOB | L3MBTL1 1287/4885MAPK1 4570/4885ALDH1A1 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.